Xerosis assessment scale quantitates dry skin severity enabling therapeutic monitoring. Visual assessment quantitates skin dryness. Transepidermal water loss measurement provides objective data. Patient-reported symptoms complement clinical assessment. Severity classification guides intervention intensity.
Clinical monitoring detects progression. Interventions reduce symptoms and infection risk. Regulatory submissions address xerosis management. Patient education emphasises skin care. Post-approval surveillance identifies treatment patterns.
General Biopharmaceutical Concepts
Xerosis Assessment Scale
Xerosis assessment scale measures the severity of dry skin to support diagnosis, treatment selection and clinical monitoring.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →